Original Study| Volume 22, ISSUE 1, P117-123.e1, January 2021

Rates of PRN Medication Administration in Australian Residential Aged Care



      To investigate administration of pro re nata (PRN) medications and nurse-initiated medications (NIMs) in Australian aged care services over a 12-month period.


      Twelve-month longitudinal audit of medication administrations.

      Setting and participants

      Three hundred ninety-two residents of 10 aged care services in regional Victoria, Australia.


      Records of PRN and NIM administration were extracted from electronic and hard copy medication charts. Descriptive statistics were used to calculate medication administration per person-month. Poisson regression was used to estimate predictors of PRN administration.


      Over a median follow-up of 12 months (interquartile range 10–12 months), 93% of residents were administered a PRN medication and 41% of residents an NIM on 21,147 and 552 occasions, respectively. The mean number of any PRN administration was 5.85 per person-month. The most frequently administered PRN medications per person-month were opioids 1.54, laxatives 0.96, benzodiazepines 0.72, antipsychotics 0.48, paracetamol 0.46, and topical preparations 0.42. Three-quarters of residents prescribed a PRN opioid or PRN benzodiazepine and two-thirds of residents prescribed a PRN antipsychotic had the medication administered on 1 or more occasions over the follow-up.

      Conclusions and Implications

      Most residents were administered PRN medications. Administration was in line with Australian regulations and institutional protocols. However, the high frequency of PRN analgesic, laxative, and psychotropic medication administration highlights the need for regular clinical review to ensure ongoing safe and appropriate use.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sluggett J.K.
        • Ilomäki J.
        • Seaman K.L.
        • et al.
        Medication management policy, practice and research in Australian residential aged care: Current and future directions.
        Pharmacol Res. 2017; 116: 20-28
        • Jokanovic N.
        • Tan E.C.
        • Dooley M.J.
        • et al.
        Prevalence and factors associated with polypharmacy in long-term care facilities: A systematic review.
        J Am Med Dir Assoc. 2015; 16 (e1–12): 535
        • Stasinopoulos J.
        • Bell J.S.
        • Ryan-Atwood T.E.
        • et al.
        Frequency of and factors related to pro re nata (PRN) medication use in aged care services.
        Res Social Adm Pharm. 2018; 14: 964-967
        • Australian Government Department of Health and Ageing
        Guiding principles for medication management in residential aged care facilities.
        (Available at:)
        • Dörks M.
        • Schmiemann G.
        • Hoffmann F.
        Pro re nata (as needed) medication in nursing homes: The longer you stay, the more you get?.
        Eur J Clin Pharmacol. 2016; 72: 995-1001
        • Roberts M.
        • King M.
        • Stokes J.
        • et al.
        Medication prescribing and administration in nursing homes.
        Age Ageing. 1998; 27: 385-392
        • Stokes J.A.
        • Purdie D.M.
        • Roberts M.S.
        Factors influencing PRN medication use in nursing homes.
        Pharm World Sci. 2004; 26: 148-154
        • Carnell K.
        • Patterson R.
        Review of national aged care quality regulatory processes.
        (Available at:)
        • Groves A.
        • Thomson D.
        • McKellar D.
        • et al.
        The Oakden Report.
        (Available at:)
      1. Royal Commission into Aged Care Quality and Safety. Interim Report: Neglect. Volume 1. Chapter 8. Canberra: Commonweath of Australia.
        (Available at:)
        • Tan E.C.
        • Visvanathan R.
        • Hilmer S.N.
        • et al.
        Analgesic use and daytime sleepiness in residents with and without dementia in residential aged care facilities.
        Drugs Aging. 2015; 32: 1045-1053
        • Lampela P.
        • Hartikainen S.
        • Sulkava R.
        • et al.
        Adverse drug effects in elderly people—a disparity between clinical examination and adverse effects self-reported by the patient.
        Eur J Clin Pharmacol. 2007; 63: 509-515
        • Vaismoradi M.
        • Amaniyan S.
        • Jordan S.
        Patient safety and pro re nata prescription and administration: A systematic review.
        Pharmacy (Basel). 2018; 6
        • Dörks M.
        • Allers K.
        • Hoffmann F.
        Pro re nata drug use in nursing home residents: A systematic review.
        J Am Med Dir Assoc. 2019; 20: 287-293
        • Douglas-Hall P.
        • Whicher E.V.
        ‘As required’ medication regimens for seriously mentally ill people in hospital.
        Cochrane Database Syst Rev. 2015; : CD003441
        • Barr L.
        • Wynaden D.
        • Heslop K.
        Nurses' attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings.
        Int J Ment Health Nurs. 2018; 27: 168-177
      2. EpiData - comprehensive data management and basic statistical analysis system. ed. Odense Denmark.
        in: Christiansen T.B. Lauritsen J.M. EpiData Association, 2010 (Available at:)
        Date accessed: April 9, 2020
        • Chen E.Y.H.
        • Wang K.N.
        • Sluggett J.K.
        • et al.
        Process, impact and outcomes of medication review in Australian residential aged care facilities: A systematic review.
        Australas J Ageing. 2019; 38: 9-25
        • Ferrah N.
        • Lovell J.J.
        • Ibrahim J.E.
        Systematic review of the prevalence of medication errors resulting in hospitalization and death of nursing home residents.
        J Am Geriatr Soc. 2017; 65: 433-442
        • Weir D.L.
        • Lee T.C.
        • McDonald E.G.
        • et al.
        Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events.
        J Am Geriatr Soc. 2020; 68: 1184-1192
        • Agit A.
        • Balci C.
        • Yavuz B.B.
        • et al.
        An iceberg phenomenon in dementia: Pain.
        J Geriatr Psychiatry Neurol. 2018; 31: 186-193
        • Brisbane South Palliative Care Collaborative
        Guide to the pharmacological management of end of life (terminal) symptoms in residential aged care residents.
        (Available at:)
      3. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of Persistent pain in older persons.
        J Am Geriatr Soc. 2009; 57: 1331-1346
      4. AMH aged care companion (online).
        Australian Medicines Handbook Pty Ltd, Adelaide2019 (Available at:)
        Date accessed: April 9, 2020
        • The Royal Australian College of General Practitioners
        Medical care of older persons in residential aged care facilities.
        (Available at:)
        • Allers K.
        • Dorks M.
        • Schmiemann G.
        • et al.
        Antipsychotic drug use in nursing home residents with and without dementia: Keep an eye on the pro re nata medication.
        Int Clin Psychopharmacol. 2017; 32: 213-218
        • Chen L.
        • Bell J.S.
        • Visvanathan R.
        • et al.
        The association between benzodiazepine use and sleep quality in residential aged care facilities: A cross-sectional study.
        BMC Geriatr. 2016; 16: 196